Nuvation Bio (NUVB) Other Working Capital Changes (2020 - 2021)
Nuvation Bio (NUVB) posted quarterly Other Working Capital Changes of $628000.0 for Q4 2021, up 59.39% year-over-year from $394000.0 in Q4 2020, and up 59.39% quarter-over-quarter from $394000.0 in Q4 2020.
Powered by 
Analysis
Nuvation Bio (NUVB) Other Working Capital Changes (2020 - 2021) Analysis & Trends
Nuvation Bio (NUVB) has reported Other Working Capital Changes for 2 consecutive years, with $628000.0 the latest figure, recorded in Q4 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Nuvation Bio | 2.38 Bn | 2.38 Bn | 30.78 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2021 | 628,000.00 |
| Dec 31, 2021 | 628,000.00 |
| Dec 31, 2020 | 394,000.00 |
| Dec 31, 2020 | 394,000.00 |